Constipation Clinical Trial
Official title:
Laparoscope Subtotal Colectomy With Anti-peristaltic Ileo-sigmoid Anastomosis for the Treatment of Slow-transit Constipation:Therapeutic Evaluation
Verified date | May 2014 |
Source | First Affiliated Hospital of Harbin Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Purpose:
To evaluate the curative effect of Laparoscope Sub-total Colectomy with Anti-peristaltic
ileosigmoid anastomosis for the treatment of slow-transit constipation on the patients with
STC.
Methods and techniques:
The data of patients with STC preformed surgery of laparoscopic subtotal colectomy with
anti-peristaltic ileosigmoid anastomosis during 2009.01-2014.05 was reviewed. The related
status such as frequency of defecation, course of constipation, laxatives use condition the
condition of using laxatives, and changes in weight were investigated. Changes of defecation
and weight, periprocedural complications (wound infection, lung infection and intestinal
fistula), long-term complication (malnutrition, abdominal pain, ileus), life satisfaction,
wexner score of pre-operation and postoperation ect were investigated in follow-ups.
Status | Completed |
Enrollment | 50 |
Est. completion date | April 2014 |
Est. primary completion date | January 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - the clinical diagnose of STC - Severe symptoms of constipation, defecating less than 2 times per week, no awareness of defecation, using laxatives to help defecation or there's no effects of laxatives. - Symptoms of constipation last at least 2 years, and ineffective effects received from medicine treatment for more than one year. - Colorectal organic disease was excluded - More than one colonic transit trials suggest dysfunction of colon transport, no significant intestinal transit dysfunction Exclusion Criteria: - significant mental disorder - surgical contraindications - Can't accept surgery subjectively |
Country | Name | City | State |
---|---|---|---|
China | The First Affiliated Hospital of Harbin Medical University | Harbin | Heilongjiang |
Lead Sponsor | Collaborator |
---|---|
Anlong Zhu |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement of signs and symptoms associated with constipation complication | preoperative, and at 6 months postoperative | ||
Secondary | Improvement of signs and symptoms associated with constipation complication | preoperative, at 12 months postoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |